Idiopathic Short Stature Drug Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

Idiopathic short stature drug market is anticipated to grow at a significant CAGR during the forecast period. Idiopathic short stature is defined as a condition in which the height of the individual is more than 2 standard deviations (SD) below the corresponding mean height for a given sex, age, and population, in whom no identifiable disorder persists. It can be subcategorized into familial and non-familial ISS, and according to pubertal delay. The market growth is attributed to the growing awareness amongst people about various hormone related disorders and thus, the rising number of growth hormone options available. Further, the growing prevalence of several genetic disorders such as Turner syndrome, Prader-Willi syndrome, and Noonan syndrome are also likely to provide a boost to the demand for idiopathic short stature drugs. Generally, there is no specific disorder of growth hormone (GH)/ insulin-like growth factor (IGF) and any other endocrine disorder, however in rare cases, idiopathic short stature can be associated with their cause.

Adding to this, the availability of insurance benefit in the developed economies such as the US further boosts the penetration of the biosimilar or biologics drugs used in the treatment of idiopathic short stature. While various treatment options are in the market majority of these are not approved for growth acceleration and hence, they are considered under off label use. Recombinant growth hormone therapy, Insulin like Growth Factor -1 (IGF-1) therapy, Aromatase inhibitors and low-dose androgen therapy (with injectable testosterone and low dose androgen) are some of the treatment options that have gain prominence in the past few years.

To Request a Sample of our Report on Idiopathic Short Stature Drug Market:  https://www.omrglobal.com/request-sample/idiopathic-short-stature-drug-market

Market Coverage

The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030

Segment Covered- 

By Product Type
By Application

Regions covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape:  Pfizer Inc., and Eli Lilly and Co., among others. 

A full Report of Idiopathic Short Stature Drug Market is Available @  https://www.omrglobal.com/industry-reports/idiopathic-short-stature-drug-market

Idiopathic Short Stature Drug Market Report by Segment

By Product

BBT-031
MMP-0201
Somatropin
Others

By Application

Hospital
Clinic
Research Center

Idiopathic Short Stature Drug Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.